Outset Medical, Inc. (OM)

Market Cap	253.03M
Revenue (ttm)	119.30M
Net Income (ttm)	-97.90M
Shares Out	17.77M
EPS (ttm)	-12.30
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	101,194
Open	14.20
Previous Close	13.93
Day's Range	14.01 - 14.25
52-Week Range	5.85 - 25.35
Beta	2.13
Analysts	Hold
Price Target	22.00 (+54.49%)
Earnings Date	Nov 5, 2025

About OM

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and Tablo...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Sep 15, 2020
• Employees: 354
• Stock Exchange: NASDAQ
• Ticker Symbol: OM
• Website: https://www.outsetmedical.com

Financial Performance

In 2024, Outset Medical's revenue was $113.69 million, a decrease of -12.80% compared to the previous year's $130.38 million. Losses were -$127.98 million, -25.94% less than in 2023.

Analyst Summary

According to one analyst, the rating for OM stock is "Hold" and the 12-month stock price target is $22.0.

Price Target

$22.0

(54.49% upside)

Analyst Consensus: Hold